Skip to main content


German pharmaceutical company Merck KGaA has launched a pilot program in Kenya and Uganda to improve the outcomes of diabetes care through a text messaging campaign...
Starting in 2012, the American Diabetes Association established the Pathway to Stop Diabetes initiative, a $1.6 million grant (paid over five years) to support the...
The latest on Medtronic’s drive to close the loop!
Can a drug long-used to treat gout be effective at preventing diabetic kidney disease?
How this “disease interception” strategy could transform our knowledge of type 1 diabetes.
Expansion of the use of Roche’s Lucentis a major step for patients.
How a single change at the FDA could lead to major improvements for patients and the healthcare system.
Why 2015 may be the “tipping point” for digital therapies in diabetes.
How a dramatic 23% increase in new diabetes cases impacts people living with diabetes nationwide.
Leaders in diabetes weigh in at The diaTribe Foundation’s second-annual event in Europe.
Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.
Paving the way to healthier food options and preventing heart disease.
New two-year study suggests red wine is beneficial for cholesterol levels.
My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”
Major organizations make it clear: diabetes education is critical!
Marks the largest ever one-time research investment from the AHA – how Google is planning to “shake it up.”
At the Children with Diabetes Friends for Life Conference this month, I had the incredible opportunity to speak to ~100 teenagers with diabetes. My talk, “10 Tips for...
Our top takeaways from the health and medicine edition of the world-famous TED conference.
Seeking to reach over 31,000 older adults with prediabetes over the next two years.
Leading ophthalmologist Dr. Ivan Suñer on what diabetic retinopathy is, how to prevent it, and what future treatments hold.